We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Waverley Pharma Acquires US based Pharmacy Canada NewsWire WINNIPEG, MB, Sept. 23, 2024 WINNIPEG, MB, Sept. 23, 2024 /CNW/ - Waverley Pharma Inc. ("Waverley Pharma" or the...
Waverley Pharma Announces Annual and Special Meeting Election Results Canada NewsWire WINNIPEG, MB, June 20, 2024 WINNIPEG, MB, June 20, 2024 /CNW/ - Waverley Pharma Inc. ("Waverley...
Waverley Pharma Business Update Canada NewsWire WINNIPEG, MB, April 30, 2024 WINNIPEG, MB, April 30, 2024 /CNW/ - Waverley Pharma Inc. ("Waverley Pharma" or the "Company"...
Waverley Pharma Announces Changes to Board of Directors Canada NewsWire WINNIPEG, MB, Nov. 22, 2023 WINNIPEG, MB, Nov. 22, 2023 /CNW/ - Waverley Pharma Inc. ("Waverley Pharma" or the...
Waverley Pharma Business Update Canada NewsWire WINNIPEG, MB, Aug. 2, 2023 WINNIPEG, MB, Aug. 2, 2023 /CNW/ - Waverley Pharma Inc. ("Waverley Pharma" or the "Company"...
Waverley Pharma Provides Business Update Canada NewsWire WINNIPEG, MB, March 20, 2023 WINNIPEG, MB, March 20, 2023 /CNW/ - Waverley Pharma Inc. ("Waverley Pharma" or the...
Waverley Pharma Provides Update on its PARP-1 Inhibitor Program Canada NewsWire WINNIPEG, MB, Jan. 11, 2023 WINNIPEG, MB, Jan. 11, 2023 /CNW/ - Waverley Pharma Inc. ("Waverley Pharma"...
Waverley Pharma Announces $3,000,000 Credit Facility Canada NewsWire WINNIPEG, MB, Aug. 5, 2021 WINNIPEG, MB, Aug. 5, 2021 /CNW/ - Waverley Pharma Inc. ("Waverley Pharma" or the...
Waverley Pharma Announces Successful Tender Award for Pemetrexed with NHS England Canada NewsWire WINNIPEG, MB, May 27, 2021 WINNIPEG, MB, May 27, 2021 /CNW/ - Waverley Pharma Inc...
Waverley Pharma Announces Successful Tender Award for Capecitabine with NHS Scotland Canada NewsWire WINNIPEG, MB, Jan. 18, 2021 WINNIPEG, MB, Jan. 18, 2021 /CNW/ - Waverley Pharma Inc. (TSXV:...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions